Fundz

Shoulder Innovations

Grand Rapids, MI · Healthcare, Health Care · 50 employees

Shoulder Innovations is a shoulder arthroplasty-focused medical device development company that designs and commercializes innovative products that demonstrate the potential for improved patient care and reduced overall cost to the healthcare system.

Funding history

  • Debt Financing — $15.0M — Jun 2026
  • Venture - Series Unknown — $20.1M — Mar 2025
  • Series E — $40.0M — Mar 2025
  • Series D — $42.0M — Mar 2023
  • Venture - Series Unknown — $32.2M — Feb 2023

Recent signals

  • Jun 26, 2026: SEC 8-K (1.01): On June 26, 2026, Shoulder Innovations, Inc. entered into a Loan and Security Agreement with Stifel Bank, marking a significant financing arrangement. This agreement includes a senior secured term loan of $15.0 million and an asset-based revolving line of credit up to $30.0 million, potentially expandable by an additional $5.0 million. The Term Loan was fully funded on the same date. This financing is expected to enhance the company's liquidity and support its operational and strategic initiatives moving forward.
  • Jun 26, 2026: Raised $15.0M in Debt Financing
  • Apr 27, 2026: SEC 8-K (7.01): On April 27, 2026, Shoulder Innovations, Inc. announced the full commercial launch of the InSet™ I-135RFX Humeral Stem via a press release. This launch marks a significant development for the company as it expands its product offerings in orthopedic implants, which could enhance market position and drive revenue growth. The press release has been furnished as an exhibit to the Form 8-K and is noted for its importance to stakeholders in understanding the company’s current operations and strategic direction.
  • Apr 27, 2026: SEC 8-K (7.01): On April 27, 2026, Shoulder Innovations, Inc. announced the full commercial launch of the InSet™ I-135RFX Humeral Stem. This launch represents a significant advancement in their product line, aiming to enhance surgical outcomes in shoulder procedures. The press release indicates that the product will be available to healthcare providers immediately, and it is expected to drive growth in the company's market share within the orthopedic sector. The launch is strategically important as it underscores the company's commitment to innovation in medical devices, which may influence their competitive positioning and revenue generation moving forward.
  • Apr 13, 2026: SEC 8-K (1.01): On April 13, 2026, Shoulder Innovations, Inc. entered into a lease agreement with Ventura Office Park Lot #8, LLC for a new commercial building of approximately 15,200 square feet located at 6320 Venture Hills Boulevard, SW, Lot 8, Byron Center, Michigan. This space will serve as the company's corporate headquarters and will include both office and warehouse facilities. The lease has an initial term of 10 years, with options for two five-year extensions and additional expansion rights, aligning with the company's long-term operational strategies.
  • Dec 03, 2025: Shoulder Innovations Announces Strategic Partnership with Interventional Systems
  • Dec 03, 2025: SEC 8-K (1.01): On December 3, 2025, Shoulder Innovations, Inc. entered into a strategic partnership with Interventional Systems to develop a robotic platform for shoulder arthroplasty. This collaboration aims at enhancing surgical precision and improving patient outcomes in shoulder procedures. The strategic implications of this partnership may include increased market share in medical technology and potential revenue growth from innovative surgical solutions. The agreement is expected to leverage both companies' expertise, though specific financial terms were not disclosed.
  • Mar 18, 2025: Raised $20.1M in Venture - Series Unknown

See plans & pricing → Track Shoulder Innovations’s funding, hiring, and signals — with verified contacts — on Fundz.